Trademark: 87179890
Word
THERAXEN
Status
Registered
Status Code
700
Status Date
Tuesday, July 9, 2019
Serial Number
87179890
Registration Number
5800746
Registration Date
Tuesday, July 9, 2019
Mark Type
4
Filing Date
Thursday, September 22, 2016
Published for Opposition
Tuesday, February 13, 2018

Trademark Owner History
Emmanuelle Meuillet - Original Registrant

Classifications
42 Biomedical services, namely, research, development, and product design for pharmaceutical products involved in the diagnosis and treatment of human diseases; Biomedical services, namely, pharmaceutical research and development, modeling and testing of pharmaceuticals and cancer diagnostic and treatment therapies; Biomedical and Laboratory services, namely, biologic assay development, preclinical pharmaceutical research, clinical research, clinical trial management, and providing in silico screening and in vitro testing of small molecules targeting Guanine nucleotide exchange factors ("GEF"s), all for pharmaceutical product research, discovery, and development purposes; consulting and advising on scientific research in the fields of small molecules and drug discovery

Trademark Events
Jan 1, 2017
Non-Final Action E-Mailed
Sep 26, 2016
New Application Entered
Sep 27, 2016
New Application Office Supplied Data Entered
Dec 29, 2016
Assigned To Examiner
Jan 1, 2017
Non-Final Action Written
Jan 1, 2017
Notification Of Non-Final Action E-Mailed
Jun 22, 2017
Teas Response To Office Action Received
Jun 22, 2017
Correspondence Received In Law Office
Jun 23, 2017
Teas/Email Correspondence Entered
Jul 13, 2017
Final Refusal Written
Jul 13, 2017
Final Refusal E-Mailed
Jan 2, 2018
Correspondence Received In Law Office
Jul 13, 2017
Notification Of Final Refusal Emailed
Jan 2, 2018
Teas Request For Reconsideration Received
Jan 2, 2018
Teas/Email Correspondence Entered
Feb 13, 2018
Published For Opposition
Jan 3, 2018
Approved For Pub - Principal Register
Jan 24, 2018
Notification Of Notice Of Publication E-Mailed
Sep 24, 2018
Use Amendment Filed
Oct 18, 2018
Statement Of Use Processing Complete
Jun 6, 2019
Su-Examiner's Amendment Written
Jun 6, 2019
Examiners Amendment E-Mailed
Jun 6, 2019
Notification Of Examiners Amendment E-Mailed
Jun 6, 2019
Assigned To Lie
Feb 13, 2018
Official Gazette Publication Confirmation E-Mailed
Apr 10, 2018
Noa E-Mailed - Sou Required From Applicant
Sep 24, 2018
Teas Statement Of Use Received
Oct 18, 2018
Case Assigned To Intent To Use Paralegal
Nov 8, 2018
Su - Non-Final Action - Written
Nov 8, 2018
Non-Final Action E-Mailed
Nov 8, 2018
Notification Of Non-Final Action E-Mailed
Jun 6, 2019
Examiner's Amendment Entered
Jun 6, 2019
Allowed Principal Register - Sou Accepted
Jun 7, 2019
Notice Of Acceptance Of Statement Of Use E-Mailed
Jul 9, 2019
Registered-Principal Register
Jul 9, 2024
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed

Trademark Alertz updated from USPTO on 2030-01-24